Allen Cooper
Academic Appointments
- Emeritus Faculty, Acad Council, Medicine - Gastroenterology & Hepatology
Key Documents
Contact Information
-
Clinical Offices
Liver Transplant Clinic 300 Pasteur Dr A160 MC 5309 Stanford, CA 94305 Tel Work (650) 498-7878 Fax (650) 498-7888Hepatology Clinic 300 Pasteur Dr A160 MC 5303 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Liver Transplantation
- Gastroenterology
- hepatology
Administrative Appointments
- Director Research Institute, Palo Alto medical Foundation (1987 - 2003)
- Chief Division of Gastroenterology and Hepatology, Stanford University (2003 - 2008)
Professional Education
| Fellowship: | UCSF Medical Center CA (1972) |
| Residency: | UCSF Medical Center CA (1971) |
| Residency: | Boston City Hospital MA (1969) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1971) |
| Residency: | UCSF Medical Center CA (1970) |
| Internship: | Boston City Hospital MA (1968) |
Scientific Focus
Current Research Interests
The liver is the central organ in the metabolism of cholesterol and other fats. Previously my basci research laboratory studied the hepatic maetaoblism of these substances in animal and cellular models. Currently my major focus is on clinical care of patients with liver disease and I am engaged in studies of the role of NAFLD (non-alcoholic liver disease) in patients with hepatits C and in post liver transplant patients.
Publications
- Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. J Viral Hepat. 2012; (2): e105-11
- Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant. 2009; (5): 1158-68
- Effectiveness of a screening program for hepatitis C. Dig Dis Sci. 2006; (5): 976-81
- LDL and cAMP cooperate to regulate the functional expression of the LRP in rat ovarian granulosa cells. J Lipid Res. 2006; (11): 2538-50
- An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Arterioscler Thromb Vasc Biol. 2005; (8): 1704-10
- Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase. J Lipid Res. 2005; (1): 27-35
Help